In-vitro detection diagnosis kit for clinical examination of prothrombin time (PT)
A technology for prothrombin time and clinical testing, which is applied in the field of in vitro diagnostic kits for the determination of prothrombin time in clinical testing, can solve problems such as poor stability, increased patient burden, and increased cost of medical units, and achieves good repeatability and stability. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0027] Example 1: Repeatability comparison with commercially available PT reagents
[0028] Add 1 g of rabbit brain powder dehydrated with acetone to 20 ml of extract (containing 0.6 g of barium sulfate, 0.63% of sodium chloride, and 0.25% of Triton X-100), shake in a water bath at 45°C for 15 min, extract the mixture at 2500 rpm, Centrifuge for 10 minutes to extract thromboplastin, and the extract is subpackaged and freeze-dried. The buffer system is made of the following raw materials: 2-8% glycine, 0.4-1.0% polyethylene glycol-8000, 8-20mM CaCl 2 , 85~110mM NaCl, 20~45mM TAPSO, 1‰ NaN 3 .
[0029] When in use, the freeze-dried product of thromboplastin was reconstituted with a certain volume of buffer, and the prothrombin time (PT) of the same normal quality control plasma (PT value: 10-14 seconds) was measured on a Pacific TS400C hemagglutination analyzer. (Table 1)
[0030] Table 1 shows that compared with commercially available reagents, the PT reagent of the present...
Embodiment 2
[0033] Embodiment two: compare with commercially available PT reagent stability
[0034] As described in Example 1, the lyophilized product of thromboplastin was reconstituted with a certain volume of buffer, and then the reconstituted reagent was stored at 2-8°C. Draw a certain volume of reagents every day, and measure the same normal quality control plasma (PT value: 10-14 seconds) on the Pacific TS400C hemagglutination analyzer, and commercially available reagents are measured simultaneously. (See Table 2 for the results)
[0035] Table 2 shows that the PT reagent of the present invention has a stable measurement result within seven days after reconstitution, and only changes on the eighth day, while commercially available reagents begin to change on the second day. Especially for small and medium hospitals, it is very important because it can reduce waste and thus reduce costs.
[0036] Table 2
[0037] Comparison with commercially available PT reagent stabilit...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com